Remicade, also known as infliximab, is an anti-inflammatory drug that works by blocking the action of tumor necrosis factor, a protein that intervenes in the processes of inflammation and immunity in the human body. Its immunosuppressive action allows treating autoimmune diseases such as rheumatoid arthritis, psoriasis, psoriatic arthritis, and Crohn's disease.
This drug is part of the so-called biological treatments, developed to combat different diseases
Remicade inhibits a chemical substance called alpha factor, of tumor necrosis, this substance is responsible for triggering inflammation in different parts of the body, in the same way it induces cell deathof lymphocytes that are abnormally activated. This medicine is given in hospitals through a very slow intravenous injection (its administration can take between 2 and 3 hours); the periodicity of its application is variable, generally, at the beginning two or three doses are grouped together and then the medication is maintained every 8 weeks; It is important to note that this drug is used very frequently in those patients who did not respond to other previous treatments or simply did not tolerate them.
This medicine is very strong, so it must be applied under medical supervision. Therefore, it is recommended that before using remicade you notify your specialist if you have a history of tuberculosis, if you have diabetes, heart conditions, multiple sclerosis, or if you are a carrier of the hepatitis B and C virus that could be aggravated by treatment..
Some of the side effects that arise when applying this drug are: increased risk of suffering from sinusitis, colds, bronchitis, urinary infections, etc. In the most severe cases there may be difficulty in breathing, swallowing, low blood pressure, swelling in the face, hands, feet, bleeding, fever, visual disturbances. If the person presents the aforementioned symptoms, it is best to notify your specialist immediately.
Remicade cannot be administered during pregnancy or when it is suspected. Women and men of childbearing potential must use adequate contraception during treatment.
